Ann: Oventus Q3 FY22 Quarterly Activity Report and Appendix 4C, page-3

If restructured has to be worth something even shell companies are worth at least $750K.
The big increase in leads is a good sign , but their operating costs are still huge and months ago they stated those same operating costs were going to be reduced , what happened to that ?
Those costs do not bode well when they only have around three months of cash left at current burn
Also the slow pace in getting the x -vent valve FDA approved is not a good sign , given the high efficacy of the valve , and given it is approved already in Canada why are not sales going through the roof in Canada as the valve would seem far better for users than a full face mask and breathing device that other manufacturers use ?
I love the Oventus device idea , but why it has not taken the market by storm beats me , I feel sorry for the company directors as they seem nice people.